← Back to Search

Behavioral Intervention

Supportive Care Models for Cancer

N/A
Recruiting
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants must speak English or Spanish
Newly diagnosed patients with a solid tumor cancer diagnosis or hematologic malignancy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3, 6, and 12 months after patient enrollment
Awards & highlights

Study Summary

This trial compares two different approaches to supportive cancer care (SCC), a technology-based approach and a team-based approach.

Who is the study for?
This trial is for English or Spanish-speaking adults newly diagnosed with solid tumor cancers or blood malignancies. They must understand and agree to participate in the study, plan to keep their current oncologist for at least a year, and not be moving from the area soon.Check my eligibility
What is being tested?
The study compares two types of supportive care for cancer patients: one uses technology like apps or online tools, while the other relies on a redesigned team approach involving healthcare professionals.See study design
What are the potential side effects?
Since this trial focuses on supportive care rather than direct medical treatments, side effects are not typical as seen with medication trials but may include discomfort from using new technologies or adjusting to team-based care interactions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I speak English or Spanish.
Select...
I have been recently diagnosed with cancer.
Select...
I can understand and am willing to consent to participate.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3, 6, and 12 months after patient enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3, 6, and 12 months after patient enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Change in health-related quality of life as assessed by the Functional Assessment of Cancer Therapy (FACT-G).
Change in patient activation using the Patient Activation Measure (PAM-13).
Change in satisfaction with care using the Consumer Assessment of Health Care (Providers and Systems (CAHPS) Cancer Care Survey Questions #39 and #42.
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Redesigned team-based supportive cancer careExperimental Treatment1 Intervention
Patients are paired with a health educator who will discuss the same educational materials from ARM A either in person or by telephone discussions weekly during months 1-4 and every other week during months 5-12.
Group II: Technology-based supportive cancer careActive Control1 Intervention
Patients receive educational materials to assist with advance care planning and symptom management through a technology-based supportive cancer care weekly during months 1-4 and every other week during months 5-12.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,408 Previous Clinical Trials
17,340,416 Total Patients Enrolled
Patient-Centered Outcomes Research InstituteOTHER
556 Previous Clinical Trials
29,944,810 Total Patients Enrolled

Media Library

Redesigned team-based supportive cancer care (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05297734 — N/A
Cancer Research Study Groups: Redesigned team-based supportive cancer care, Technology-based supportive cancer care
Cancer Clinical Trial 2023: Redesigned team-based supportive cancer care Highlights & Side Effects. Trial Name: NCT05297734 — N/A
Redesigned team-based supportive cancer care (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05297734 — N/A
~1923 spots leftby Jan 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top